Chinese healthcare firms to raise $2 billion in HK IPOs

China NT Pharma and Shanghai Pharmaceuticals aim to raise as much as $2 billion in Hong Kong IPOs this month.

Chinese healthcare firms to raise $2 billion in HK IPOs
They might hurt, but the increasing popularity of vaccines in China is good news for NT Pharma

Hong Kong investors are preparing for an influx of healthcare equities that could absorb $2 billion of capital in the coming weeks as two Chinese pharmaceutical companies roll out plans for initial public offerings.

Shanghai Pharmaceuticals, which is already listed in its home city, said last month that shareholders had approved the company’s H-share offering plan and that the China Securities Regulatory Commission had accepted its listing application. Last week, the company raised its original...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES